Literature DB >> 31744458

Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial.

Shubhadeep D Sinha1, Vamsi Krishna Bandi1, Bala Reddy Bheemareddy1, Pankaj Thakur2, Sreenivasa Chary1, Kalpana Mehta3, Vikranth Reddy Pinnamareddy4, Rajendra Pandey5, Subhramanyam Sreepada6, Santosh Durugkar7.   

Abstract

Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.

Entities:  

Year:  2019        PMID: 31744458     DOI: 10.1186/s12882-019-1515-7

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


  1 in total

1.  Comparative effectiveness of erythropoietin alpha and beta in hemodialysis patients: a single-center prospective observational study.

Authors:  Muhammad Nadeem Ahsan; Naila Asif; Shafqat Waqar Khanzada; Muhammad Sohaib Asghar; Farah Yasmin; Faran Khalid; Shameen Fareed; Syeda Ghazala Irshad
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.